Salarius Pharmaceuticals, Inc.SLRX

Market cap

$1.39M

P/E ratio

	2014/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12
Cash and cash equivalents	-	-	-	-	10	4	11	29	12	6	2
Marketable securities, current	-	25	39	14	-	-	-	-	-	-	-
Total cash & short-term investments	-	-	-	-	10	4	11	29	12	6	2
Accounts receivable, net	-	-	12,181	10,385	9,939	-	-	-	-	-	-
Inventories	-	-	454,132	431,891	186,920	-	-	-	-	-	-
Total current assets	34	92	62	35	10	5	16	30	15	7	3
Property, plant and equipment, net	85,144	382,437	556,315	331,040	74,460	25,016	22,639	7,880	-	-	-
Marketable securities, non-current	-	2	-	-	-	-	-	-	-	-	-
Total non-current assets	1	3	747,710	457,635	74,460	9	9	11	130,501	66,850	35,412
Total assets	36	95	63	35	10	14	25	41	15	7	3
Accounts payable	578,653	875,646	1	2	342,530	2	2	2	3	602,853	936,994
Total current liabilities	1	3	4	6	1	-	-	-	-	-	-
Total non-current liabilities	51,410	30,029	8,398	39,214	-	-	-	-	-	-	-
Total liabilities	1	3	4	6	1	3	3	2	4	1	2
Common stock and paid-in capital	1	129	136	140	4	23	42	71	74	82	83
Retained earnings	-8,010,860	-37,152,490	-76,645,613	-111,079,275	-132,961,275	-12,076,700	-19,428,954	-32,197,192	-63,805,148	-76,347,841	-81,923,618
Stockholders' equity	-6,538,340	92	59	29	9	11	22	39	10	5	2
Working capital	-	-				-	-	-	-	-	-